ARCUTIS BIOTHERAPEUTICS INC. - COMMON STOCK
13.24
31-一月-25 16:45:01
15 分钟延时
股票
-0.43
-3.15%
今日范围
13.16 - 13.85
ISIN
N/A
来源
NASDAQ
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 12月 2023 22:00:49 条件 Nasdaq GlobeNewswire
-
29 11月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Announces Third Quarter 2023 Financial Results and Provides Business Update
03 11月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 11月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Report Third Quarter 2023 Financial Results
25 10月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
20 10月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Announces Pricing of $100 Million Public Offering
19 10月 2023 23:45:47 条件 Nasdaq GlobeNewswire
-
Arcutis Announces Proposed Public Offering
19 10月 2023 16:04:44 条件 Nasdaq GlobeNewswire
-
06 10月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 10月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Appoints L. Todd Edwards as Chief Commercial Officer
27 9月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
25 9月 2023 09:00:47 条件 Nasdaq GlobeNewswire
-
19 9月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 9月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
12 9月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
Arcutis to Present at Upcoming Investor Conference
05 9月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Publishes Annual Environmental, Social, and Governance (ESG) Report
31 8月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Arcutis Launches First Television Ad for ZORYVE® (Roflumilast) Cream 0.3%
29 8月 2023 08:00:00 条件 Nasdaq GlobeNewswire